Chimeric viruses between SIV(mac) and various HIV-1 isolates have biological properties that are similar to those of the parental HIV-1

AIDS

Volumn 10, Issue 12, 1996, Pages 1331-1337

  Kuwata, Takeo ^a   Shioda, Tatsuo ^b   Igarashi, Tatsuhiko ^a   Ido, Eiji ^a   Ibuki, Kentaro ^a   Enose, Yoshimi ^a   Stahl Hennig, Christiane ^c   Hunsmann, Gerhard ^c   Miura, Tomoyuki ^a   Hayami, Masanori ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c GERMAN PRIMATE CENTER   (Germany)

Author keywords

Animal model; Cynomolgus monkey; HIV 1; Neutralization; Replicative capacity; Simian human immunodeficiency virus

Indexed keywords

GAG PROTEIN; MONOCLONAL ANTIBODY; NEF PROTEIN; POL PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; VPR PROTEIN; VPU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMERA; CONTROLLED STUDY; FEMALE; GENE CONSTRUCT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MALE; MONKEY; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; ANIMAL; GENETIC REASSORTMENT; GENETICS; MACACA; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; HIV-1; HUMANS; MACACA; REASSORTANT VIRUSES; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 0029658057     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199610000-00004     Document Type: Article

References (47)

1. Matsushita S, Robert-Guroff M, Rusche J, et al.: Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J Virol 1988, 62:2107-2114.
2. Matthews TJ, Langlois AJ, Robey WJ, et al.: Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc Natl Acad Sci USA 1986, 83:9709-9713.
3. Putney SD, Matthews TJ, Robey WG, et al.: HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science 1986, 234:1392-1395.
4. Weiss RA, Clapham PR, Cheingsong-Popov R, et al.: Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS risk patients. Nature 1985, 316:69-71.
5. Goudsmit J, Debouck C, Meloen RH, et al.: Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc Natl Acad Sci USA 1988, 85:4478-4482.
6. Palker TJ, Clark ME, Langlois AJ, et al.: Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc Natl Acad Sci USA 1988, 85:1932-1936.
7. Rusche JR, Javaherian K, McDanal C, et al.: Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci USA 1988, 85:3198-3202.
8. Fisher AG, Ensoli B, Looney D, et al.: Biologically diverse molecular variants within a single HIV-1 isolate. Nature 1988, 334:444-447.
9. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR: Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991, 253:71-74.
10. Cann AJ, Churcher MJ, Boyd M, et al.: The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism. J Virol 1992, 66:305-309.
11. Kuiken CL, de Jong JJ, Baan E, Keulen W, Tersmette M, Goudsmit J: Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J Virol 1992, 66:4622-4627.
12. O'Brien WA, Koyanagi Y, Namazie A, et al.: HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 1990, 348:69-73.
13. Shioda T, Levy JA, Cheng-Mayer C: Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 1991, 349:167-169.
14. Asjo B, Morfeldt-Manson L, Albert J, et al.: Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 1986, ii:660-662.
15. Cheng-Mayer C, Seto D, Tateno M, Levy JA: Biologic features of HIV-1 that correlate with virulence in the host. Science 1988, 240:80-82.
16. Fenyo EM, Morfeldt-Manson L, Chiodi F, et al.: Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 1988, 62:4414-4419.
17. Tersmette M, Lange JMA, De Goede REY, et al.: Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1989, i:983-985.
18. Tersmette M, Gruters RA, de Wolf F, et al.: Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol 1989, 63:2118-2125.
19. Fultz PN, McClure HM, Anderson DC, Switzer WM: Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). AIDS Res Hum Retroviruses 1989, 5:397-409.
20. Hirsch VM, Martin JE, Dapolito G, et al.: Spontaneous substitutions in the vicinity of the V3 analog affect cell tropism and pathogenicity of simian immunodeficiency virus. J Virol 1994, 68:2649-2661.
21. Sharma DP, Zink MC, Anderson M, et al.: Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytotropic parental virus: pathogenesis of infection in macaques. J Virol 1992, 66:3550-3556.
22. Marthas ML, Banapour B, Sutjipto S, et al.: Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus. J Med Primatol 1989, 18:311-319.
23. Rudensey LM, Kimata JT, Benveniste RE, Overbaugh J: Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population. Virology 1995, 207:528-542.
24. Kuwata T, Igarashi T, Ido E, et al.: Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication. J Gen Virol 1995, 76:2181-2191.
25. Igarashi T, Shibata R, Hasebe F, et al.: Persistent infection with SIV mac chimeric virus having tat, rev, vpu, env and nef of HIV-1 in macaque monkeys. AIDS Res Hum Retroviruses 1994, 10:1021-1029.
26. Sakuragi S, Shibata R, Mukai R, et al.: Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus. J Gen Virol 1992, 73:2983-2987.
27. Shibata R, Kawamura M, Sakai H, Hayami M, Ishimoto A, Adachi A: Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J Virol 1991, 65:3514-3520.
28. Sauermann U, Schneider J, Mous J, et al.: Molecular cloning and characterization of a German HIV-1 isolate. AIDS Res Hum Retroviruses 1990, 6:813-823.
29. Cheng-Mayer C, Shioda T, Levy JA: Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J Virol 1991, 65:6931-6941.
30. Adachi A, Gendelman HE, Koenig S, et al.: Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J Virol 1986, 59:284-291.
31. Clapham PR, Weiss RA, Dalgleish AG, Exley M, Whitby D, Hogg N: Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester. Virology 1987, 158:44-51.
32. Harada S, Koyanagi Y, Yamamoto N: Infection of HTLV-III/LAV in HTLV-1-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 1985, 229:563-566.
33. Perno CF, Baseler MW, Broder S, Yarchoan R: Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp-120 binding, even in the presence of enhancing antibodies. J Exp Med 1990, 171:1043-1056.
34. Naidu YM, Kestler HM III, Li Y, et al.: Characterization of infectious molecular clones of simian immunodeficiency virus (SIV-MAC) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVMAC. J Virol 1988, 62:4691-4696.
35. Willy RL, Smith DH, Laskey LA, et al.: In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 1988, 62:139-147.
36. Kestler III HW, Ringler DJ, Mori K, et al.: Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991, 65:651-662.
37. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, Desrosiers RC: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992, 258:1938-1941.
38. Luciw PA, Pratt-Lowe E, Shaw KE, Levy JA, Cheng-Mayer C: Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc Natl Acad Sci USA 1995, 92:7490-7494.
39. Schuitemaker H, Meyaard L, Koostra NA, et al.: Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. J Infect Dis 1993, 168:1140-1147.
40. Shibata R, Hoggan MD, Broscius C, et al.: Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo. J Virol 1995, 694453-4462.
41. Ghosh SK, Fultz PN, Keddie E, et al.: A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology 1993, 194:858-864.
42. O'Brien WA, Koyanagi Y, Namazie A, et al.: HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 1990, 348:69-73.
43. Li J, Load CI, Haseltine W, Letvin NL, Sodroski J: Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J Acquir Immune Defic Syndr 1992, 5:639-646.
44. Voss G, Li J, Manson K, Wyand M, Sodroski J, Letvin NL: Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys. Virology 1995, 208:770-775.
45. Li JT, Halloran M, Load CI, et al.: Persistent infection of macaques with simian-human immunodeficiency virus. J Virol 1995, 69:7061-7071.
46. Igarashi T, Kuwata T, Takehisa J, et al.: Genomic and biological alteration of an HIV-1/SIVmac chimeric virus having HIV-1 Env recovered from a long-term carrier monkey. J Gen Virol 1996, 77:1649-1658.
47. + T cells and AIDS in pig-tailed macaques. J Virol 1996, 70:3189-3197.